Dr Henno Martin
BM BCh (Oxon) MA (Cantab) PGDip (Oncology) MRCP FRCR
Languages spoken
English, German
Expert in
Breast & Prostate cancer
Overview
Dr Henno Martin is a Consultant Clinical Oncologist at Cambridge University Hospitals, caring for people with prostate, breast, and bladder cancers.
He takes a warm, personalised approach to treatment, combining expert clinical care with the latest advances in cancer research.
Dr Martin trained at some of the UK’s leading medical centres, including Oxford and Cambridge, and is actively involved in research to improve how cancer is detected and monitored, particularly through the use of blood tests known as liquid biopsies.
He regularly contributes to national cancer studies and works closely with patients to ensure their care is tailored to their individual needs and preferences. Patients appreciate his clear communication, attention to detail, and strong focus on both medical excellence and emotional support.
Find me on
LinkedIn
BUPA
Shelford Oncology
Cambridge Urology Partnership
I was drawn to oncology because it combines cutting-edge science with deeply human care. It’s a privilege to support people through such a meaningful part of their journey.
Current position(s)
- Consultant Clinical Oncologist, GenesisCare Cambridge
- Consultant Clinical Oncologist, at Addenbrooke’s Hospital
- Targeted therapies
- Genomic medicine
- Supportive care
- Cell-free DNA
- Prostate
- Bladder
- Breast cancer
- SABR
- Brachytherapy
- Fellow of the Royal College of Radiologists, Member of the European Society for Medical Oncology
Prostate cancer detection through unbiased capture of methylated cell-free DNA
iScience, 2024 Martin HW et al. A study advancing non-invasive detection of prostate cancer using novel liquid biopsy techniques.
Read on ScienceDirect
Cancer in Pregnancy (CARING): a retrospective study of cancer diagnosed during pregnancy in the UK
British Journal of Cancer, 2024
Martin HW et al. National collaborative research on cancer management during pregnancy.
Read on Nature
Added value of diffusion-weighted MRI for nodal radiotherapy planning in pelvic malignancies
Clinical and Translational Oncology, 2019
Martin HW et al. Improving imaging precision for pelvic cancer radiotherapy.
Read on SpringerLink